Found: 11
Select item for more details and to access through your institution.
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia—An interim report.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 803, doi. 10.1002/pds.5008
- By:
- Publication type:
- Article
Capture of biologic and biosimilar dispensings in a consortium of U.S.‐based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 778, doi. 10.1002/pds.4934
- By:
- Publication type:
- Article
Reviewers of manuscripts submitted in 2019: With appreciation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 817, doi. 10.1002/pds.5078
- Publication type:
- Article
A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 796, doi. 10.1002/pds.4957
- By:
- Publication type:
- Article
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 770, doi. 10.1002/pds.4933
- By:
- Publication type:
- Article
Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 786, doi. 10.1002/pds.4908
- By:
- Publication type:
- Article
Using real‐world data to evaluate biosimilar switching.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 814, doi. 10.1002/pds.4899
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 821, doi. 10.1002/pds.4825
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 1, doi. 10.1002/pds.4949
- Publication type:
- Article
Barriers and facilitators to conduct high‐quality, large‐scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 811, doi. 10.1002/pds.4885
- By:
- Publication type:
- Article
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 757, doi. 10.1002/pds.4809
- By:
- Publication type:
- Article